Chronic Myeloid Leukaemia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Chronic myeloid leukaemia
Marked leukocytosis with full myeloid maturation spectrum, basophilia, splenomegaly, and BCR-ABL1 positivity (Philadelphia chromosome) is diagnostic of CML in chronic phase. First-line treatment is a tyrosine kinase inhibitor (imatinib, dasatinib, or nilotinib). Monitoring via BCR-ABL1 transcript quantification every 3 months.
Reference: WHO – 2022 – Myeloid Neoplasm Classification; ELN 2024 CML Guidelines